Harpoon Therapeutics, Inc. Annual Return On Equity in % from 2018 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Harpoon Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2022.
  • Harpoon Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2023 was -895 %, a 351% decline year-over-year.
  • Harpoon Therapeutics, Inc. annual Return On Equity for 2022 was -300 %, a 111% decline from 2021.
  • Harpoon Therapeutics, Inc. annual Return On Equity for 2021 was -142 %, a 92.2% decline from 2020.
  • Harpoon Therapeutics, Inc. annual Return On Equity for 2020 was -74 %, a 52.3% decline from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -300 -158 -111% Jan 1, 2022 Dec 31, 2022
2021 -142 -68.2 -92.2% Jan 1, 2021 Dec 31, 2021
2020 -74 -25.4 -52.3% Jan 1, 2020 Dec 31, 2020
2019 -48.6 -114 -174% Jan 1, 2019 Dec 31, 2019
2018 65.7 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.